Correction: small/mid-cap flow
Markets are inside a 14–18 month correction, yet institutions are buying small‑ and mid‑cap funds after many names fell 60–65% — a valuation play some pros are leaning into (x.com). At the same time the S&P 500 and Nasdaq sit under their 200‑day moving averages, prompting advice to use SIPs/staggered buys, keep a margin of safety, and favor defensive hospitals while avoiding microfinance and import‑heavy manufacturers (x.com)(x.com).
Domestic institutional investors (DIIs) purchased about ₹32,786.92 crore of Indian equities in March 2026, a pace analysts say is propping up demand for smaller-cap stocks. Small‑cap mutual funds recorded a renewed inflow of ₹2,942 crore in January 2026 as fund managers increased allocations to cheaper small‑cap names. Multiple Indian market screens show dozens of mid‑ and small‑cap stocks have slid 50–60% from prior peaks, with one compilation listing 63 names down as much as ~61% during 2025. CNBC‑TV18 flagged individual cases such as Mangalore Refinery & Petrochemicals (MRPL) trading roughly 60% below earlier highs as of recent reporting on mid/small‑cap drawdowns. Technicals: as of March 18, 2026 the S&P 500’s 200‑day simple moving average stood at about 6,615.71 while the index price was ~6,626.77, placing the S&P marginally above its 200‑day line on that date. Similarly, the NASDAQ‑100’s 200‑day SMA was ~24,318.22 with the index trading near 24,380 on mid‑March prints, indicating both US benchmarks were hovering around but slightly above their 200‑day averages as of those readings. Fund houses increased cash buffers in February 2026 — adding roughly ₹3,544 crore to reach about ₹2.09 lakh crore of cash across schemes — a tactical reserve cited by analysts as the source of recent selective small/mid‑cap buying. Market commentaries and MF platforms are urging staggered SIPs and disciplined, margin‑of‑safety buying into small/mid caps while keeping higher cash cushions; guidance from sector writeups and advisers has repeatedly highlighted staggered SIPs as the preferred approach amid volatility. Analysts are singling out healthcare/hospitals as a defensive sector in the current volatility, while flagging microfinance and import‑dependent manufacturers as higher‑risk exposures due to regulatory and currency pressures. Regulatory moves and macro pressures underpin those warnings: the finance ministry has discussed capping lending rates for microfinance companies under a credit‑guarantee plan, and rupee weakness has pushed up hedging costs and import bills—factors analysts say amplify downside for import‑heavy manufacturers.
